LivingGLP1
Study S002437

Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study

Registration

Registration
NCT07001553
Acronym
GLaD
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
37
Start
2025-05-28
Primary completion
2026-01-07
Lead sponsor
Australian Catholic University
Conditions
Obesity; Type 2 Diabetes Mellitus (T2DM)
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Feasibility of recruitment [4 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.